| 000 | 01858cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030752.0 | ||
| 008 | 130216s2012 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.22.M.Sc.2012.Re.P | ||
| 100 | 0 | _aReem Bader Amin Alhashdy | |
| 245 | 1 | 0 |
_aPrevalence of preclinical renal nephropathy in obese patients with knee osteoarthritis, preliminary data / _cReem Bader Amin Alhashdy ; Supervised Amr Mohammed Amin , Hania Salah Zayed , Jehan Younes |
| 246 | 1 | 5 | _aمعدل حدوث التغيرات الكلويه تحت الاكلينكيه من مرضى السمنه المصاحب لخشونة الركبتين-معلومات مبدئيه |
| 260 |
_aCairo : _bReem Bader Amin Alhashdy , _c2012 |
||
| 300 |
_a149 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Nuclear Medicine | ||
| 520 | _aThe prevalence of obesity has increased worldwide. Chronic kidney disease has been associated with obesity. The development of chronic kidney disese is usually the culminating result of interaction of multiple risk factors including obesity and metabolic syndrome of cardiovascular risk factors. Patients with knee osteoarthritis (OA) are frequently obese and due to the combined effects of obesity and chronic use of non-steroidal anti-inflammatory drugs may represent a high risk group for renal disease | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aGER | |
| 653 | 4 | _aKOA | |
| 653 | 4 | _aTG | |
| 700 | 0 |
_aAmr Mohammed Amin , _eSupervisor |
|
| 700 | 0 |
_aHania Salah Zayed , _eSupervisor |
|
| 700 | 0 |
_aJehan Younes , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c41520 _d41520 |
||